TNFSF10 and endometrial cancer: Additionally, endometrial cancer organoids can be utilized to identify new therapeutic targets for endometrial cancer [87], study mechanisms of platinum-based drug resistance [88], and investigate sensitivity to death receptor ligand TRAIL therapy [89].